The Legal 500

Twitter Logo Youtube Circle Icon LinkedIn Icon

CMS

1 WEST REGENT STREET, GLASGOW, G2 1AP, SCOTLAND
Tel:
Work 0141 222 2200
Fax:
Fax 0141 222 2201
Email:
Web:
www.cms-cmck.com
Aberdeen, Algiers, Amsterdam, Antwerp, Barcelona, Beijing and 70 more

Carina Healy

Tel:
Work 0141 304 6032
Email:
CMS

Work Department

IP/IT.

Position

Carina is partner in our Technology team with over 20 years experience advising on commercial and IP related transactions. She specialises in lifesciences and acts for a range of biotech, speciality pharma, medical device and medical technology companies. She also has a focus on academic institutions, having worked closely with long standing clients University of Glasgow, Dundee University, and University College London for many years.

Carina regularly advises her clients on large, complex and strategically important IP and commercial arrangements, including in and out licensing, clinical trials, strategic alliances, technology development collaborations, and manufacturing, supply and distribution agreements.  She is known for being commercial and pragmatic in finding ways to help her clients and their partners achieve outcomes which are beneficial for both parties

Career

Trained Dundas & Wilson CS LLP; qualified 1997; partner 2007; partner CMS Cameron McKenna 2014.

Member

The Law Society of Scotland; The Law Society of England and Wales.

Education

University of Glasgow (1994 LLB Hons; 1995 Dip LP).


London: TMT (technology, media and telecoms)

Pharmaceuticals and biotechnology

Within: Pharmaceuticals and biotechnology

CMS significantly enhanced its healthcare practice when it merged with Olswang LLP and Nabarro LLP in May 2017. The combined team now covers the full spectrum of life sciences matters, with particular strength in handling patent litigation and big-ticket M&A transactions. In an illustration of its track record in the patent space, it is advising a leading global pharmaceutical company on potential patent infringement claims against generic companies, and is advising a pharmaceuticals company on the challenges to SPC validity (including the validity of paediatric extensions to SPCs) concerning a number of different pharmaceutical products. Other mandates included assisting Convergence Pharmaceuticals on the £524m sale of the company to Biogen Idec, advising CooperSurgical on the acquisition of the business and assets relating to the Wallace product line from Smiths Medical International, and representing GlaxoSmithKline in its appeal to the Competition Appeal Tribunal against infringement findings and penalties imposed by the Competition and Markets Authority (CMA) following a reverse patent settlement competition investigation in the UK. Key figures include Niall McAlister, David Day, Sarah Hanson and Carina Healy, who are the names to note for corporate and commercial transactions; patent attorney Robert Stephen, who is highly recommended for his opposition and appeal experience at the EPO; Shuna Mason, who is singled out for regulatory, compliance and product liability cases; Brian Sher and Caroline Hobson, who focus on EU and UK competition matters; and patent litigator Gareth Morgan, ‘a super star’ with notable experience of acting in IP trials concerning patent entitlement, patent validity and infringement, SPCs and the interpretation of IP licences. Patent specialist Jane Hollywood has been heavily involved in securing European patent protection for the high-profile CRISPR-Cas9 gene-editing tool. Other representative clients include Medtronic, Bayer, Eli Lilly, Boston Scientific and Sandoz.

[back to top]

Scotland: Public sector

Education

Within: Education

CMS’s ‘client-friendly and commercially minded’ team has ‘excellent knowledge of the university sector’ and is praised as ‘providing an outstanding service in a timely manner’. Recent highlights include acting for longstanding client the University of Glasgow on all aspects of its multimillion-pound campus redevelopment project. Darina Kerr, who has ‘excellent knowledge of the real estate sector’, acted for the Glasgow School of Art on its acquisition of the former Stow College from Glasgow Kelvin College, while ‘effective communicatorCarina Healy, who is also noted for ‘her outstanding knowledge of the life sciences sector alongside an immensely pragmatic approach and excellent inter-personal skills’, advised the University of Aberdeen on the creation of Islexa Limited, a new university spin-out which is developing a novel technology to produce laboratory grown islets (the organoids responsible for insulin production). This included assistance with the negotiation of the licence and management agreement with Cell and Gene Therapy Catapult. Team head Laurence Ward advised the University of Dundee on the procurement of a cloud-based integrated business solution.

[back to top]

Scotland: TMT (technology, media and telecoms)

Intellectual property

Within: Leading individuals

Carina Healy - CMS

Within: Intellectual property

The ‘very good and responsive’ team at CMS provides ‘a client-friendly service’ and acts for clients in the higher education, life sciences, sports, natural resources and entertainment sectors. Team head Laurence Ward advised the Scottish Exhibition and Conference Centre (SEC) on sponsorship agreements with A.G. Barr, Bacardi-Martini, Clydesdale Bank and Sony Europe, as well as amendments to its ticketing agreement with Ticketmaster and a supply and pouring rights agreement with Heineken. The ‘personable and pragmaticCarina Healy is ‘an effective communicator’ who is noted for her ‘experience in technology transfer matters’; she scores highly with clients for ‘working incredibly hard to ensure tight deadlines are met’. Healy advised the Stratified Medicine Scotland Innovation Centre on IP aspects arising from its new strategic research collaboration with AstraZeneca, and the University of Glasgow on its licensing arrangements with animal health company Merial. In another highlight, she assisted the University of Aberdeen with the drafting of an IP assignation agreement with Cell and Gene Therapy Catapult following the client’s creation of a spin-out company, which is developing a novel technology to produce laboratory grown islets (the organoids responsible for insulin production).

[back to top]


Back to index

Legal Developments by:
CMS

  • Access to justice: protective costs orders in planning challenges

    Third parties and competing developers have no rights of appeal to the Secretary of State against planning decisions. Disappointed applicants can appeal to the Secretary of State and can have the merits of the application reconsidered. The only remedy available to a disappointed third party is a challenge by way of judicial review in the High Court on a point of law. The sense of frustration and disempowerment this creates has not been helped by the increasing complexity of the planning process and the use of consultation to legitimise decisions that many perceive may already have been taken.
    - CMS Group

Legal Developments worldwide

Legal Developments and updates from the leading lawyers in each jurisdiction. To contribute, send an email request to